tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Corey Davis, 39 are a BUY (82.98%), 8 are a HOLD (17.02%).
Analyst Corey Davis, carries an average stock price target met ratio of 68.33% that have a potential upside of 48.81% achieved within 363 days. Previously, Corey Davis worked at LIFESCI.
Corey Davis’s has documented 77 price targets and ratings displayed on 9 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ZYNE, Zynerba Pharmaceuticals at 14-Aug-2023.
Analyst best performing recommendations are on ZYNE (ZYNERBA PHARMACEUTICALS).
The best stock recommendation documented was for ZYNE (ZYNERBA PHARMACEUTICALS) at 8/8/2017. The price target of $7 was fulfilled within 1 day with a profit of $0.73 (11.64%) receiving and performance score of 116.43.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell
$1
$0.86 (614.29%)
$2
3 years 5 months 20 days ago
(08-May-2022)
4/5 (80%)
$-0.2 (-16.67%)
77
Hold
$2
$1.86 (1328.57%)
$4
3 years 5 months 20 days ago
(08-May-2022)
6/8 (75%)
$0.8 (66.67%)
137
Hold
$1
$0.86 (614.29%)
$3
3 years 5 months 23 days ago
(05-May-2022)
8/18 (44.44%)
$-0.42 (-29.58%)
74
Buy
$6
$5.86 (4185.71%)
$11
3 years 7 months 20 days ago
(08-Mar-2022)
1/4 (25%)
$3.53 (142.91%)
250
Hold
3 years 11 months 24 days ago
(04-Nov-2021)
1/2 (50%)
$10.51 (91.47%)
83
What Year was the first public recommendation made by Corey Davis?
